Phathom Pharmaceuticals files Form 8-K
Phathom Pharmaceuticals filed a Form 8-K on October 29.
Related stories
OncoSil Medical Q1 FY27 Sales Revenue Rises 45.8% Year On Year
M impact | EQUITY | Oct 30, 2026, 01:20 AM UTC
Xreality Group Posts Quarterly Annual Recurring Revenue of A$8.8 Million
M impact | EQUITY | Oct 30, 2026, 01:20 AM UTC
Hiremii Posts Q1 FY27 Revenue of A$7.056 Million
M impact | EQUITY | Oct 30, 2026, 01:19 AM UTC
Reece Reports Q1 FY27 Sales Revenue of A$2,510 Million
M impact | EQUITY | Oct 30, 2026, 01:19 AM UTC
Reece Reports Q1 FY27 Sales Revenue of A$2.510 Billion
M impact | EQUITY | Oct 30, 2026, 01:19 AM UTC
Xi S&D Q3 Operating Profit Falls 72.66% Year on Year
M impact | EQUITY | Oct 30, 2026, 01:17 AM UTC